PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: Dr Gilman

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

New Medication 'Weapon' To Stop Opiate Addiction Says Dr. Stephen Gilman - Buprenorphine (Suboxone, Subutex), the medication federally approved in 2002 to treat opiate addiction is barely reaching its audience of addicted people - Suboxone-Treatment-NewYork.com / DrGilman.com
New Medication 'Weapon' To Stop Opiate Addiction Says Dr. Stephen Gilman

 

NewswireToday - /newswire/ - New York City, NY, United States, 2006/08/09 - Buprenorphine (Suboxone, Subutex), the medication federally approved in 2002 to treat opiate addiction is barely reaching its audience of addicted people - Suboxone-Treatment-NewYork.com / DrGilman.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Most with pain killer and heroin addiction do not even know it exists, and few NYC physicians are qualified to prescribe it.

“Of the 75,559 physicians licensed to practice in New York State, only 398 are listed with the government as credentialed to use buprenorphine – that’s a pathetically low 0.52% of physicians”, says Stephen Gilman, M.D., one of NYC’s most respected experts on addiction treatment. “It’s always been a problem that most physicians are frightened of treating addicted patients, but now these MD’s don’t even know where to send these patients”

Dr. Gilman is a powerful, experienced and entertaining interview. He will tell your audience:

- Exactly what to expect from the treatment process – its easier and simpler that you think;
- Why you always want a physician with more than the minimal required training. Skimp on this and treatment can backfire;
- What type of advanced training and expertise is ideal to treat opiate addiction;
- The number ONE reason opiate addicts don’t seek out treatment, and how this misconception can be changed in a minute;
- How to easily locate a qualified physician in YOUR area in less than 5 minutes.

Dr. Gilman (drgilman.com) is a board certified Addiction Psychiatrist in NYC, is on the faculty of a major NYC medical school, and consultant to numerous substance abuse rehabilitation facilities. He has been interviewed for both the print and radio media.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Dr Gilman

 
 

Availability: All Metropolitan Area

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


New Medication 'Weapon' To Stop Opiate Addiction Says Dr. Stephen Gilman

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Stephen Gilman, M.D. - DrGilman.com 
212-717-9138 media[.]drgilman.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Dr Gilman securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Dr Gilman / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Occupational Medicine Market Estimated to Expand At A Robust CAGR Over 2025 Notes PMR
Persistence Market Research Publishes Traditional Chinese Medicine Market Forecast Over 2017-2025
Inferior Vena Cava Filters Market to Register A Strong Growth by 2025 Notes Persistence Market Research
Plasma Component Separator Market Set to Surge Significantly During 2017-2025 Says PMR
Persistence Market Research Releases Fertility Enhancing Treatment Market Snapshot by 2017-2025
Disposable Diabetes Devices Market Expected to Generate Huge Profits by 2025 Finds Reports Persistence Market Research
Cardiac Biomarkers Market Expected to Generate Huge Profits by 2017-2025 Reports PMR
Stone Management System Market Foreseen to Grow Exponentially Over 2017-2025 Finds PMR
Global Hemoglobinopathy Market Worth US$ 788M by 2024 According to Persistence Market Research
Dentsu Announces its Corporate Venture Capital Fund Dentsu Ventures Investment in Grail
Xenex Receives Top Honors from Frost & Sullivan for LightStrike™ - the Only Pulsed Xenon UV Disinfection System in the Healthcare Market
Partners HealthCare and GE Healthcare Launch 10-year Collaboration to Integrate Artificial Intelligence into Every Aspect of the Patient Journey
US Acute Care Solutions Celebrates 2-Year Anniversary
GE Healthcare Receives FDA Indication Approval for Visipaque™ (iodixanol) Injection for use with Coronary CT Angiography
Telehealth Vendors Expand mHealth Portfolio to Conquer New Growth Opportunities Finds Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit RightITnow Ltd

Visit  MagLar, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)